Non-tuberculous mycobacterial pneumonia

Active Ingredient: Rifabutin

Indication for Rifabutin

Population group: only adults (18 years old or older)

For this indication, competent medicine agencies globally authorize below treatments:

450-600 mg once a day

Route of admnistration

Oral

Defined daily dose

450 - 600 mg

Dosage regimen

From 450 To 600 mg once every day for 180 day(s)

Detailed description

450-600 mg in combination regimens for up to 6 months after negative cultures are obtained.

When rifabutin is given in association with clarithromycin (or other macrolides) and/or fluconazole (or related compounds) the rifabutin dosage may need to be reduced to 300 mg.

Active ingredient

Rifabutin

Rifabutin is an antibiotic used to treat tuberculosis and prevent and treat Mycobacterium avium complex.

Read more about Rifabutin

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.